IV 

116TH CONGRESS 

2D SESSION H. RES. 1040 

Supporting the designation of July 2020 as Uterine Fibroids Awareness 

Month. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 1, 2020 

Mr. DAVID SCOTT of Georgia (for himself, Ms. CLARKE of New York, Ms. 

BLUNT ROCHESTER, Mr. CONNOLLY, Ms. MOORE, Mr. HURD of Texas, 

Ms. NORTON, Mrs. LAWRENCE, Mr. BUTTERFIELD, Mr. RUSH, Mr. GRIJALVA, and Mr. VAN DREW) submitted the following resolution; which 

was referred to the Committee on Energy and Commerce 

RESOLUTION 

Supporting the designation of July 2020 as Uterine Fibroids 

Awareness Month. 

Whereas fibroids may cause significant morbidity through 

their presence in the uterus and pelvic cavity, causing 

significant pelvic pain, abnormal uterine bleeding, reproductive dysfunction, miscarriages, and even infertility; 

Whereas the pain, discomfort, stress, and other physical and 

emotional symptoms of living with fibroids may significantly interfere with a woman’s quality of life, compromising her ability to function normally, work, or care for 

her family, and may lead to more severe health and 

wellness issues; 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HRES 1040 IH 

Whereas uterine fibroids are the most prevalent medical condition affecting women, with an estimated 30 percent of 

women developing a uterine fibroid by age 35, and 80 

percent of women developing a uterine fibroid by age 50; 

Whereas the exact number of affected women is unknown, as 

early detection and diagnosis are difficult because only 1 

out of 4 women who have a uterine fibroid exhibit symptoms severe enough to require treatment; 

Whereas the overall incidence of uterine fibroids is estimated 

to disproportionately impact Black and Hispanic women, 

who also experience more severe symptoms, resulting in 

an incidence rate that is 3 times greater in women with 

Black ancestry and 2 times greater in Hispanic women 

compared to Caucasian women; 

Whereas a hysterectomy, or removal of the uterus, is among 

the most common surgical treatments for uterine 

fibroids, and more than 200,000 hysterectomies are performed each year to treat uterine fibroids, at an estimated annual cost of more than $2,000,000,000; 

Whereas uterine fibroids were estimated to cost the United 

States $5,900,000,000 to $34,400,000,000 annually with 

an estimated annual lost work cost of $1,600,000,000 to 

$17,200,000,000 through absenteeism and short-term 

disability in women ages 25 to 54; and 

Whereas public awareness and education campaigns on uterine fibroids prevention, screening, and symptoms are held 

during the month of July each year: Now, therefore, be 

it 

1 Resolved, That the House of Representatives— 

2 (1) supports the goals and ideals of Uterine 

3 Fibroids Awareness Month; 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HRES 1040 IH 

1 (2) recognizes the disparity in incidence rates 

2 for Black and Hispanic uterine fibroid patients; 

3 (3) recognizes the need for greater research, 

4 treatment, and care options regarding uterine 

5 leiomyoma; and 

6 (4) encourages the President to issue a procla7 mation calling upon the people of the United States 

8 to observe the month with appropriate awareness 

9 and educational activities. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS